immunotherapy
TCF1 (T Cell Factor 1) is a transcription factor that marks progenitor, stem-like CD8+ T cells with self-renewal capacity. TCF1+ CD8+ T-cell subsets, often co-expressing PD-1, are associated with durable responses to immune checkpoint blockade and are considered a favorable phenotype for sustained antitumor immunity, in contrast to terminally exhausted T-cell states.
Related terms
Source papers
- Parkin activates innate immunity and promotes antitumor immune responses doi:10.1172/JCI180983
- Parkin Induces Ubiquitination and Large Extracellular Vesicle Release of HMGB1 to Activate Antitumor Immunity doi:10.1158/0008-5472.CAN-25-0904